Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA 2006;296:2105 11. 226. Foody JM, Shah R, Galusha D, et al. Statins and mortality among elderly patients hospitalized with heart failure. Circulation 2006;113: 1086 92. 227. Kjekshus J, Apetrei E, Barrios V, et al. Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007;357:2248 61. 228. Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008;372:1231 9. 229. Macchia A, Levantesi G, Franzosi MG, et al. Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocar- dial infarction treated with n-3 polyunsaturated fatty acids. Eur J Heart Fail 2005;7:904 9. 230. Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of n-3 poly- unsaturated fatty acids in patients with chronic heart failure (the GISSI- HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008;372:1223 30. 231. McMurray JJ, Dunselman P, Wedel H, et al. Coenzyme Q10, rosuvas- tatin, and clinical outcomes in heart failure: a pre-speci ed substudy of CORONA (Controlled Rosuvastatin Multinational Study in Heart Failure). J Am Coll Cardiol 2010;56:1196 204. 232. Soukoulis V, Dihu JB, Sole M, et al. Micronutrient de ciencies an unmet need in heart failure. J Am Coll Cardiol 2009;54:1660 73. 233. Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II DAVIT II). Am J Cardiol 1990;66:779 85. 234. Goldstein RE, Boccuzzi SJ, Cruess D, et al. Diltiazem increases late- onset congestive heart failure in postinfarction patients with early reduction in ejection fraction: the Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group. Circulation 1991;83:52 60. 235. Waldo AL, Camm AJ, deRuyter H, et al. 